LANSOPRAZOLE TEVA 30 MG

Country: Israel

Bahasa: Inggeris

Sumber: Ministry of Health

Bahan aktif:

LANSOPRAZOLE

Boleh didapati daripada:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Kod ATC:

A02BC03

Borang farmaseutikal:

CAPSULES

Komposisi:

LANSOPRAZOLE 30 MG

Laluan pentadbiran:

PER OS

Jenis preskripsi:

Required

Dikeluarkan oleh:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Kumpulan terapeutik:

LANSOPRAZOLE

Kawasan terapeutik:

LANSOPRAZOLE

Tanda-tanda terapeutik:

For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. Healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (GORD) or duodenal ulcer. Prevention of relapse in patients with GORD or duodenal ulcer. Eradication of H. Pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). Short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. Long-term management of pathological hypersecretory conditions including Zollinger Ellison syndrome. Treatment and prophylaxis of NSAID- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment.

Tarikh kebenaran:

2010-07-31

Risalah maklumat

PATIENT LEAFLET IN ACCORDANCE
WITH THE PHARMACISTS’
REGULATIONS
(PREPARATIONS) – 1986
The medicine is dispensed with a
doctor's prescription only
LANSOPRAZOLE TEVA 30 MG
Capsules
COMPOSITION:
Each capsule contains:
Lansoprazole 30 mg
For information regarding inactive
ingredients and allergens, see section
2 - “Important information about some
ingredients of the medicine” and section
6 - “Additional information”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE
USING THE MEDICINE.
This leaflet contains concise information
about the medicine. If you have additional
questions, refer to the doctor or the
pharmacist.
This medicine has been prescribed for
treatment of your illness. Do not pass it
on to others. It may harm them even if it
seems to you that their illness is similar.
1. WHAT IS THE MEDICINE INTENDED FOR?
•
Lansoprazole Teva inhibits the secretion
of gastric acid and is therefore effective
in treating acid-related disorders in the
upper gastrointestinal tract.
•
For the treatment of gastric ulcer,
duodenal ulcer, reflux oesophagitis,
gastroesophageal reflux disease
(GERD).
•
For prolonged and maintenance
treatment to prevent recurrence of
gastroesophageal reflux disease (GERD)
or duodenal ulcer.
•
For combined treatment with antibiotics
for the eradication of Helicobacter pylori
(_H. pylori_), which is one of the main
causes of peptic ulcer and gastritis.
•
For short-term treatment (up to 4 weeks)
of dyspeptic effects caused by excessive
gastric acidity, such as heartburn and/or
upper abdominal pain.
•
For long-term treatment in hypersecretory
conditions, including Zollinger-Ellison
syndrome.
•
For the treatment and prophylaxis of
peptic ulcer caused by treatment with
non-steroidal anti-inflammatory drugs
(NSAIDs), and for the relief of symptoms
in patients receiving prolonged treatment
with NSAIDs.
THERAPEUTIC CLASS
Proton pump inhibitors (PPI).
2. BEFORE USING THE MEDICINE:
DO NOT USE THIS MEDICINE IF:
•
You are sensitive (allergic) to the active
ingredient (Lansoprazole) or to any o